Implementation of hepatitis C cure in Australia: one year on

OBJECTIVES: Direct-acting antivirals (DAAs) for the treatment of hepatitis C (HCV) became universally available in Australia in March 2016, with an aim to achieve HCV elimination. Fourteen per cent of Australians with HCV have initiated treatment. The objective of this study was to explore and ident...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Virus Erad
Hlavní autoři: Richmond, Jacqueline A, Wallace, Jack
Médium: Artigo
Jazyk:Inglês
Vydáno: Mediscript Ltd 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892669/
https://ncbi.nlm.nih.gov/pubmed/29682304
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky